Lord Abbett Health Care Fund Class F3 (LHCOX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
22.66
+0.25 (1.12%)
Feb 17, 2026, 9:30 AM EST
Fund Assets8.70M
Expense Ratio0.68%
Min. Investment$1,500
Turnover91.00%
Dividend (ttm)0.08
Dividend Yield0.37%
Dividend Growth-23.43%
Payout Frequencyn/a
Ex-Dividend DateDec 2, 2025
Previous Close22.41
YTD Return-0.83%
1-Year Return13.14%
5-Year Return14.07%
52-Week Low16.72
52-Week High23.87
Beta (5Y)n/a
Holdings60
Inception DateJul 31, 2019

About LHCOX

Lord Abbett Health Care Fund Class F3 is a mutual fund focused on the health care sector, designed to achieve long-term capital appreciation by investing primarily in equity and equity-related securities of companies involved in health care and biotechnology. The fund typically allocates at least 80% of its assets to health care-related firms, covering industries such as pharmaceuticals, medical devices, health care services, and biotechnology. Its portfolio spans both U.S. and international companies, offering diversified exposure to the global health care market. With 58 holdings as of the latest data, the fund seeks to capture growth opportunities driven by innovation, demographic changes, and advancements in medical technology. The fund has a net expense ratio of 0.68% and does not require a minimum investment. Lord Abbett Health Care Fund Class F3 plays a specialized role in the market by providing investors targeted access to one of the most vital and dynamic sectors of the global economy, aligning with the MSCI ACWI Health Care Index as its benchmark.

Fund Family Lord Abbett
Category Health
Performance Rating Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol LHCOX
Share Class Class F3
Index MSCI ACWI/Health Care NR Index

Performance

LHCOX had a total return of 13.14% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.60%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
LHCVXClass R60.68%
LHCFXClass F0.78%
LHCIXClass I0.78%
LHCTXClass R50.78%

Top 10 Holdings

36.77% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY8.85%
argenx SEARGX4.02%
Gilead Sciences, Inc.GILD3.51%
AstraZeneca PLCAZN3.49%
Tarsus Pharmaceuticals, Inc.TARS3.16%
Natera, Inc.NTRA3.00%
Guardant Health, Inc.GH2.91%
Cencora, Inc.COR2.74%
EssilorLuxottica Société anonymeEL2.66%
ABIVAX Société AnonymeABVX2.43%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 2, 2025$0.084Dec 2, 2025
Nov 26, 2024$0.1097Nov 26, 2024
Nov 22, 2022$0.0471Nov 22, 2022
Nov 23, 2021$1.4724Nov 23, 2021
Nov 24, 2020$2.3345Nov 24, 2020
Nov 21, 2019$0.0104Nov 21, 2019
Full Dividend History